✕
Login
Register
Back to News
Inhibrx Biosciences Q4 EPS $(2.11) Misses $(2.08) Estimate
Benzinga Newsdesk
www.benzinga.com
Positive 42.3%
Neg 0%
Neu 0%
Pos 42.3%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment